CD8+ T Cells Are Effector Cells of Contact Dermatitis to Common Skin Allergens in Mice  by Vocanson, Marc et al.
CD8þ T Cells Are Effector Cells of Contact
Dermatitis to Common Skin Allergens in Mice
Marc Vocanson1, Anca Hennino1, Magalie Cluzel-Tailhardat1, Pierre Saint-Mezard1, Josette Benetiere1,
Cyril Chavagnac1, Frederic Berard1,2, Dominique Kaiserlian3 and Jean-Franc¸ois Nicolas1,2
Allergic contact dermatitis (ACD) to strong experimental haptens is mediated by specific CD8þ T cells. Here, we
show that similar mechanisms occur for weak haptens, which comprise the vast majority of chemicals
responsible for human ACD. We used a model of ACD, that is, the contact hypersensitivity reaction, to test for
the allergenicity of three weak haptens involved in fragrance allergy. ACD to weak haptens could not be
induced in normal mice. In contrast, mice acutely depleted in CD4þ T cells developed a typical ACD reaction to
the three weak fragrance allergens that peaked 24 hours after challenge. Priming of CD8þ T cells was observed
in draining lymph nodes 5 days after sensitization and development of ACD was associated with the infiltration
of activated CD8þ T cells in the challenged skin. CD8þ T cells were effectors of the ACD reaction as in vivo
treatment with depleting anti-CD8 mAbs abrogated the ACD responses and as purified CD8þ T cells could
adoptively transfer ACD to naive recipients. In conclusion, our data demonstrate a dominant role of CD8þ T
cells as initiators of ACD to weak haptens, and suggest that CD8þ T cells may represent potential targets for
preventing or treating ACD.
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INTRODUCTION
Allergic contact dermatitis (ACD), also referred to as contact
hypersensitivity (CHS), is a T-cell-mediated skin inflamma-
tory reaction because of repeated skin exposure to contact
allergens, that is, non-protein chemicals called haptens
(Lepoittevin and Leblond, 1997; Saint-Mezard et al.,
2004b). Haptens comprise very diverse chemicals, including
a limited number of strong contact sensitizers and thousands
of weak haptens responsible for human ACD.
Knowledge of the pathophysiology of human ACD derives
mainly from murine models of ACD to strong haptens, for
example, 2,4-dinitrofluorobenzene (DNFB) and oxazolone
(OXA), which are used mainly in experimental models of
CHS and are able to sensitize more than 90% of naive
individuals after a single skin contact. Development of CHS
to strong haptens proceeds in two phases (Saint-Mezard et al.,
2004b). The sensitization (afferent) phase, induced by
epicutaneous exposure to a hapten, is initiated by activation
of skin innate immunity and leads to the priming of hapten-
specific effector T cells in draining lymph nodes (LNs). The
elicitation (efferent) phase, generated upon skin re-exposure
to the same hapten, induces the recruitment into the skin of T
cells resulting in ACD through IFN-g production and
cytotoxicity towards keratinocytes (Kehren et al., 1999; Traidl
et al., 2000; Trautmann et al., 2001; Akiba et al., 2002).
Although CHS can be mediated by both CD4þ T cells and
CD8þ T cells (Gocinski and Tigelaar, 1990; Kohler et al.,
1995), recent studies have emphasized that specific CD8þ
cytotoxic T cells are effector cells of CHS to the majority of
strong haptens (i.e. DNFB, 2,4-dinitrochlorobenzene (DNCB),
2,4,6-trinitrochlorobenzene (TNCB), OXA) in normal C57/
BL6 and BALB/c mice, whereas CD4þ T cells behave as
downregulatory cells (for a review see Bour et al., 1995; Xu
et al., 1996; Kehren et al., 1999; Martin et al., 2000; Akiba
et al., 2002; Dubois et al., 2003; Martin, 2004; Saint-Mezard
et al., 2004a).
Weak haptens including dyes, preservatives, perfumes,
metal ions, and drugs are the most frequently encountered
haptens in humans (Saint-Mezard et al., 2004b; Uter et al.,
2005). They can induce sensitization in a small proportion of
individuals only and mostly those who frequently manipulate
the hapten (occupational disease) (Buckley et al., 2002).
However, the mechanisms by which weak haptens induce
specific T-cell-mediated skin inflammation are unknown.
Indeed, attempts to develop ACD to weak haptens in mice
have failed so far.
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We postulated that the pathophysiology of CHS to
weak haptens is similar to that of CHS to strong haptens
and involves CD8þ effector T cells. Therefore, we tested
the ability of several weak haptens involved in fragrance
allergy (a-hexylcinnamaldehyde (HCA), eugenol (EUG), and
hydroxycitronellal (HDCL)) to induce an ACD reaction in
normal mice and in mice acutely depleted in CD4þ T cells.
We report here data confirming our hypothesis and showing
that CD8þ T cells are effector cells of ACD to weak contact
allergens.
RESULTS
Weak contact sensitizers are unable to induce ACD in normal
mice
CHS was tested using standard protocols where C57BL/6
mice were sensitized at day 0 (for strong haptens) or at three
consecutive days (day 2, 1, and 0, for weak haptens)
by skin painting on the abdomen and challenged 5 days later
by hapten painting on the ear. DNFB and OXA, two strong
experimental haptens, induced a classical CHS response
which peaked at 24 hours post-challenge (Figure 1). In
contrast, no CHS reaction could be obtained with the three
fragrance allergens, that is, HCA, EUG, and HDCL, or with a
chemical devoid of sensitizing properties: isopropanol (ISOP)
(Figure 1), even when administered at high concentrations
over three consecutive days.
ACD to weak haptens can develop in CD4þ T-cell-deficient
mice and is mediated by CD8þ T cells
We next tested the hypothesis that mice depleted in CD4þ T
cells could develop ACD to fragrance allergens. C57BL/6
mice (and in some experiments MHC class II/ mice) were
acutely depleted in CD4þ T cells by in vivo anti-CD4 mAb
treatment throughout the CHS protocol. Lymphoid organs
from CD4þ T-cell-depleted C57BL/6 (and class II/) mice
contained less than 0.5% of CD4þ T cells and more than
90% of CD8þ T cells.
CD4þ T-cell-deficient mice developed a robust CHS
reaction to the three weak haptens HCA, EUG, and HDCL
(Figure 2). Kinetic studies revealed that optimal CHS response
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Figure 1. CHS to strong and weak haptens. C57BL/6 mice were sensitized
by a single strong hapten application (DNFB, OXA) at day 0, or by three
applications of weak haptens (HCA, EUG, HDCL) and of a chemical devoid of
sensitizing properties (ISOP) at days 2, 1, 0 and challenged at day 5 (black
bars). Naive controls were similarly ear-challenged (white bars). Results are
expressed as the mean ear swelling7SD at 24 hours post-challenge. They are
representative of three different experiments with 4 mice per group.
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Figure 2. CHS reactions to weak haptens develop in CD4þ T-cell-depleted mice. (a) CHS responses. CD4þ T-cell-depleted (black bars), CD8þ T-cell-
depleted (light gray bars) CD4þ /CD8þ T-cell-depleted (dark gray bars), and untreated (white bars) mice were sensitized with HCA, EUG, HDCL, and ISOP and
challenged 5 days later. Results are expressed as the mean ear swelling7SD at 24 hours post-challenge. They are representative of three different experiments
with four mice per group. (b–d) Histological analysis. Unsensitized mice (b), HCA-sensitized undepleted mice (c) and HCA-sensitized CD4þ T-cell-depleted
mice (d) were challenged at day 5 by HCA painting on the ear. Ear biopsies were taken at 24 hours post-challenge and processed for routine histology. HES
staining. Original magnification  30. (e) Reverse transcription-PCR analysis of CD8, IFN-g and hypoxanthine phosphoribosyltransferase mRNA expression in
the skin during the elicitation phase of CHS to HCA. mRNAs were obtained from the ears of HCA-sensitized undepleted and CD4þ T-cell-depleted mice, 24
and 48 hours after HCA challenge. Controls include ears of naive mice (naive) and of unsensitized challenged mice (UnS). Results are representative of three
different experiments.
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occurred at 24 hours post-challenge. Depletion of CD8þ
T cells in CD4þ T-cell-depleted mice completely abrogated
the CHS responses to all three weak haptens (Figure 2a). The
CHS responses were hapten-specific as they developed only
upon challenge with the sensitizing weak hapten, but not
after DNFB challenge. No CHS response was induced by the
chemical ISOP, used as negative control (Figure 2a).
Examination of ear sections of CHS to HCA from CD4þ
T-cell-depleted mice showed histological changes character-
istic of classical CHS including abundant inflammatory
infiltrating cells, dermal edema, and vascular enlargement
(Figure 2b–d). No histological change was observed in
HCA-sensitized and -challenged non-depleted mice and in
naive HCA-‘‘challenged only’’ CD4þ T-cell-depleted mice
(Figure 2b–d).
We next analyzed the presence of CD8 and IFN-g mRNA
in the ear skin by semiquantitative reverse transcription-PCR
analysis at different times after challenge (Figure 2e). No
IFN-g or CD8 transcript was found in skin of HCA-sensitized
and challenged mice. In contrast, anti-CD4 mAb treatment
resulted in high levels of IFN-g and CD8 transcripts at 24 and
48 hours after HCA challenge, correlating with the CHS
response.
Priming of CD8þ T cells in LNs during the afferent phase of
CHS to weak haptens
In vivo priming of CD8þ T cells in draining LNs was tested
using an IFN-g enzyme-linked immunospot assay assay.
LN cells from day 5 HCA-sensitized (or ISOP-sensitized)
mice were cultured overnight with submitogenic doses of the
phytohemagglutinin. No IFN-g spot-forming cells (SFC) were
detected in total LN cells from normal undepleted mice
sensitized either with HCA or ISOP (Figure 3a). Similarly,
no hapten-induced IFN-g SFC were found in LN cells of
CD8þ T cell-depleted mice. In contrast, LN cells from
HCA-immunized CD4þ T-cell-depleted mice contained a
high frequency of SFC (100 IFN-g SFC/105 LN cells) (Figure
3a) indicating that priming of CD8þ T cells had occurred.
Depletion of CD8þ T cells prevented the development of
IFN-g SFC in LNs of CD4þ T-cell-depleted mice (Figure 3a).
Production of IFN-g in the culture supernatants tested by
ELISA showed a high IFN-g synthesis by LN cells from HCA-
immunized CD4þ T-cell-depleted mice whereas no IFN-g
was produced by LN cells from HCA-immunized undepleted
mice (Figure 3b). As previously shown for CHS to strong
haptens, IFN-g in response to sensitization with weak haptens
was only produced by the CD8þ T-cell subset. Indeed, IFN-g
was found in cultures of purified CD8þ LN T cells but not
in cultures of CD8þ T-cell-depleted LN cells from HCA-
sensitized and CD4þ T-cell-depleted mice (data not shown).
Taken together, these data show that CHS to weak haptens
is associated with the priming of IFN-g producing CD8þ
T cells in draining LNs.
CD8þ T cells can transfer CHS to weak haptens to naive
recipients
That CD8þ T cells are effector cells of CHS to weak haptens
was confirmed by adoptive intravenous transfer experiments
in CD3e/ mice. A strong CHS reaction developed in
CD3e/ mice which received 20106 LN CD8þ T cells
from day 5 HCA-sensitized CD4þ T-cell-depleted mice and
were ear-challenged 1 day later with HCA (Figure 4).
Conversely, challenging the transferred mice with an
irrelevant hapten (DNFB) failed to generate a CHS response.
DISCUSSION
The present study shows that the pathophysiology of ACD to
clinically relevant contact allergens is similar to that of ACD
to experimental haptens and involves CD8þ effector T cells.
The afferent phase leads to the priming of CD8þ T cells in
LN draining the skin in contact with the hapten. The efferent
phase corresponds to the recruitment of activated CD8þ
T cells at the site of hapten challenge and to the development
of the skin allergic reaction. The weak haptens studied here
are chemicals responsible for fragrance allergy (Buckley
et al., 2000; Frosch et al., 2002; Johansen, 2003; Svedman
et al., 2003), a high morbidity form of ACD mainly because
everybody is exposed to fragrances or perfumed products
found in the air, in foods, and in cosmetics. However,
fragrance allergy affects only a small percentage of exposed
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Figure 3. HCA-induced CD8þ T-cell responses. LN cells from HCA-sensitized (black bars) or ISOP-sensitized (gray bars), undepleted, CD4þ T-cell-depleted,
CD8þ T-cell-depleted, and CD4þ /CD8þ T-cell-depleted mice were collected at day 5 post-sensitization and restimulated with submitogenic doses of
phytohemagglutinin (5mg/ml). (a) IFN-g SFC and (b) IFN-g secretion were determined after 20 hours of cell culture. Results are representative of three different
experiments with four mice per group.
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individuals. The reason why only some individuals become
sensitized to the chemical is not known.
Several factors directly control the development of ACD,
such as conditions of exposure (frequency, dose and
duration, route of administration) (Kimber et al., 2003),
genetic polymorphisms of xenobiotic-metabolizing enzymes
(Griem et al., 1998), and environmental factors including
psychological stress (Saint-Mezard et al., 2003). Our results
also suggest that sensitization to a contact allergen may result
from defective immune downregulatory mechanisms. Indeed,
that ACD to fragrance allergens can develop in CD4þ T-cell-
depleted mice demonstrated that those chemicals have
the intrinsic potential to induce specific T-cell immune
responses. However, in mice with normal numbers of CD4þ
T cells, specific immunity cannot be activated to develop
effectors cells of ACD.
Numerous studies have documented that CD4þ T cells
comprise various subsets endowed with downregulatory
properties. Hence, Th2 cells, IL-10-producing Tr1 cells, and
natural CD4þCD25þ T cells were reported to be involved
in the control and resolution of ACD to strong haptens
(Biedermann et al., 2001; Dubois et al., 2003; Foussat et al.,
2003). Although the experiments performed here were not
designed to determine the subset of CD4þ regulatory/
suppressive T cells able to prevent CHS to weak haptens, it
is tempting to speculate that the aforementioned subpopula-
tions are involved in this phenomenon. Indeed, we found that
CD4þCD25þ T cells (that may include both natural and
hapten-induced regulatory CD4þ T cells) potently regulate
CD8þ T-cell response to fragrance allergens in normal mice
(Figure S1, see Supplementary Material). The mechanisms by
which Treg cells inhibit CHS to weak contact allergens
remains to be clarified.
The inability of weak haptens to sensitize normal
individuals may be related to their low irritant/toxic proper-
ties. Although the sensitizing properties of haptens are linked
to their ability to generate new antigenic determinants
following interaction with self-proteins, their intrinsic pro-
inflammatory properties are mandatory for optimal immuno-
genicity. Indeed, activation of skin innate immunity by
haptens is required for differentiation and mobilization of
DC from the skin to draining LNs and for optimal priming of
CD8þ T-cell precursors (Enk and Katz, 1992; Flint et al.,
1998). In contrast to strong haptens, weak haptens are unable
to induce skin inflammation at the site of skin contact or
may generate only a mild skin irritancy, even using high
concentrations of chemicals. Recent in vivo animal tests that
have been developed to assess the allergenicity of chemicals
have revealed that the sensitizing potential of haptens
correlates to their proinflammatory properties. The most
reliable test, referred to as the local lymph node assay,
measures the hapten-induced proliferation of cells in the LNs
draining the site of hapten painting (Kimber et al., 2002).
Strong haptens induce a high proliferation rate whereas weak
haptens are responsible for only a modest proliferation of
LN cells (Basketter et al., 2000). Taken together our results
suggest that, in the absence of activation of skin innate
immunity, CD8þ effector T cells of CHS cannot develop.
Future studies are required to confirm that the patho-
physiology of human ACD to weak haptens is similar to that
reported here using experimental murine CHS and to further
investigate the respective roles of innate immunity, CD4þ
Treg cells and CD8þ effector T cells in sensitization to
common contact allergens. The availability of a murine
model of CHS to weak haptens will undoubtedly allow a
better characterization of the regulatory/suppressive mechan-
isms involved in ACD in order to define the best strategies to
prevent or treat this very common skin disease.
MATERIALS AND METHODS
Mice
Female C57BL/6 mice (6–10 week old) were purchased from Charles
River Laboratories (L’Arbresle, France). C57BL/6 mice with a
mutation in the Ab gene (MHC class II/) and in the CD3e cluster
(CD3e/) were, respectively, provided by C. Benoist/D. Mathis
(Harvard Medical School, Boston, MA) and M. Malissen (Centre
d’Immunologie, Marseille-Luminy, France). Heterozygous knockout
mice were backcrossed for more than eight generations to C57BL/6
and used to generate the offspring of the present study. All
experimental procedures were in accordance with the Comite´
re´gional d’e´thique pour l’expe´rimentation animale guidelines on
animal welfare.
Allergens
DNFB (Sigma, Saint Quentin Fallavier, France), OXA (Sigma), HCA
(Aldrich, Saint Quentin Fallavier, France), EUG (Sigma), HDCL
(Aldrich), and ISOP (Carlos Erba, Val de Reuil, France) were
prepared in acetone/olive oil (4:1 vol/vol), freshly before application.
Assay for CHS: the mouse ear swelling test
CHS to experimental haptens. CHS to strong haptens was tested
in C57BL/6 mice. The mouse ear swelling test procedure for the
study of CHS to experimental haptens has been described elsewhere
(Garrigue et al., 1994). Briefly, mice were sensitized epicutaneously
on day 0 by application of 25 ml of 0.5% DNFB or 2% OXA diluted
Ear swelling (m)
Contact hypersensitivity
response: 24 hoursSensitization ChallengeGroup
CD3−/−
recipients
A
B
C
D
E
F
DNFB
DNFB
No
HCA
HCA
No
CD4+ 
T-cell-depleted
donors
DNFB
HCA
DNFB
HCA
DNFB
HCA
0 40 80 120 160 200
P<0.001
P<0.001
Figure 4. Adoptive transfer of CD8þ T cells from HCA-sensitized CD4þ
T-cell-depleted mice confer hapten-specific CHS to HCA in CD3e/
recipient mice. Naı¨ve CD3e/ mice were transferred intravenous with
20 106 CD8þ LN T cells from naı¨ve mice (Groups C and F) or from HCA-
sensitized (day 5; Groups D and E) or DNFB-sensitized (day 5; Groups A and
B) CD4þ T-cell-depleted mice. Recipient CD3e/ animals were challenged
1 day after transfer with HCA (Groups B, D, and F) or DNFB (Groups A, C,
and E). Results are expressed as the mean ear swelling7SD at 24 hours
post-challenge. They are representative of three different experiments with
four mice per group.
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in acetone/olive oil (4:1) onto abdominal skin and challenged on day
5 with 5ml of a non-irritant concentration of 0.15% DNFB or 0.2%
OXA applied onto the left ear. Measurements using a spring-loaded
micrometer (J15, Blet SA, Lyon, France) were performed before and
at 24-hour intervals after challenge. Ear swelling was calculated by
subtracting the initial value from the value recorded on the
corresponding day, and further subtracting any swelling recorded
for the vehicle-control ear from the swelling recorded for the hapten-
challenge ear.
CHS to weak haptens. CHS to weak fragrance haptens was tested
in wild-type C57BL/6 mice and in CD4þ T-cell-depleted C57BL/6
mice. In some experiments, we used CD4þ T-cell-deficient MHC
class II/ mice. Indeed, total depletion of CD4þ T cells was more
easily obtained in MHC class II/ mice that are genetically deficient
in CD4þ T cells and contain only 5% of the normal numbers
of CD4þ T cells found in wild-type C57BL/6 mice. Mice were
sensitized on three consecutive days (day 2, day 1, day 0) by
epicutaneous application of 50 ml of HCA (75%), EUG (75%), HDCL
(75%), or ISOP (100%) onto abdominal skin, and challenged 5 days
after the last sensitization dose with 12.5 ml of a non-irritant
concentration of HCA (40%), EUG (60%), HDCL (60%), or ISOP
(100%) onto the left ear.
Antibody depletion of CD4þ and CD8þ T cells in vivo
The rat anti-mouse CD4 mAb GK 1.5 was obtained from
American Type Culture Collection (Rockville, MD) and the rat
anti-mouse CD8 mAb H35.17.2 was kindly provided by G. Milon
(Institut Pasteur, Paris, France). Hybridomas were grown as ascites in
pristane-primed Swiss-nude mice. Mice were given intraperitoneal
injections of 20mg of anti-CD4 mAbs or 16 mg of anti-CD8 mAbs in
200ml on days 3, 2, 1 and þ 4. Depletions 498% were
observed in all the experiments.
RNA extraction and reverse transcription-PCR analysis of CD8
and IFN-c mRNA
At different intervals (24, 48 hours) after challenge, ear samples were
collected from sensitized or unsensitized mice and frozen in liquid
nitrogen. The detection of RNA was conducted as described in detail
elsewhere (Akiba et al., 2002).
Purification of T-cell subsets
Draining LNs from HCA-sensitized mice (day 2, 1, 0) were
harvested on day 5 to prepare single-cell suspensions. CD8þ T cells
were purified using anti-CD8 mAb-coated microbeads and positive
selection columns (Myltenyi Biotech, Bergish Gladbach, Germany).
Purity was routinely more than 95%.
IFN-c enzyme-linked immunospot assay
The number of IFN-g-producing cells was determined using an
enzyme-linked immunospot assay assay. Briefly, 96-well-nitrocellu-
lose plates (MAHA N4510, Millipore, Saint Quentin-en-Yvelines,
France) were coated overnight at 41C with anti-IFN-g-antibody
(R46A2, BD-Pharmingen, Le Pont de Claix, France) and blocked
with phosphate-buffered saline/1% BSA for 2 hours at 371C. The
plates were washed five times with phosphate-buffered saline/Tween
0.05% before use. Inguinal draining LNs of mice sensitized at day
2, 1, 0 with HCA or ISOP were harvested at day 3 and cell
suspensions were prepared. LN cells were dispensed in the plates
(105/well) and incubated with 5mg/ml phytohemagglutinin-P (Sig-
ma) overnight at 371C, 5% CO2. After washing, plates were
incubated for 2 hours at 371C, 5% CO2 with a biotinylated
anti-IFN-g-antibody (XMG1.2, BD-Pharmingen). IFN-g SFCs were
developed using avidin horse radish peroxidase (CliniSciences,
Montrouge, France) incubated for 20 minutes at room temperature,
and extensively washed before adding the substrate (aminoethyl
carbazole, Sigma). The number of IFN-g SFCs present in each well
was counted using the Carl Zeiss vision enzyme-linked immunospot
assay (Carl Zeiss Vision, D-85399, Hallberghoos, Germany) and the
results were expressed as IFN-g SFCs/105 LN cells.
IFN-c ELISA assay
Inguinal draining LNs of mice sensitized at day 2, 1, 0 with HCA
or ISOP were harvested at day 3 and cell suspensions were prepared.
A total of 2 million LN cells/ml was cultured in 96-well plates in
RPMI complete medium, in the presence of 5 mg/ml phytohemag-
glutinin. Cell-free supernatants were harvested after 20 hours, and
IFN-g production was titrated by ELISA using the R&D System (Lille,
France) DuoSet kit following the manufacturer’s protocol. In some
experiments, CD8þ T cells were purified from LN cells on positive
selection columns (Myltenyi Biotech) and IFN-g secretion was
assessed both on the CD8 positive fraction and on the CD8 negative
fraction.
Adoptive transfer of CHS
Axillary and inguinal LNs from CD4þ T-cell-deficient mice (naı¨ve
or sensitized with HCA or DNFB) were harvested 5 days after
sensitization and used to prepare single LN cell suspensions and
purified CD8þ T cells. 20 106 cells/200 ml saline were transferred
intravenously through the orbital vein into naı¨ve syngenic CD3e/
mice. Recipient mice were challenged 1 day after cell transfer and
CHS was measured by ear swelling the following days. The CD3e/
mice are genetically deficient in T cells and are therefore more
appropriate for transfer experiments of CHS than wild-type C57BL/6
mice (personal data).
Statistical analysis
Statistical analyses were performed using the paired two-tailed
Student’s t-test. Po0.05 was used as the level of significance.
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SUPPLEMENTARY MATERIAL
Figure S1. CD4þCD25þ T cells inhibit HCA-induced CD8þ T-cell
activation and IFN-g secretion in vitro. CD8þ T cells (5104) were isolated
from day 5 HCA-sensitized, CD4þ T-cell-depleted C57BL/6 mice. They
were stimulated for 20 hours by submitogenic doses of phytohemagglutinin
(5 mg/ml) in the absence (gray bar) or in the presence of purified CD4þ T cells
or FACS-sorted CD4þCD25þ T cells from either naive (white bars) or day
5 HCA-sensitized (black bars) C57BL/6 mice. IFN-g secretion in 20 hours
culture supernatants was titrated by ELISA. Results are expressed as % of IFN-g
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production of control wells containing CD8þ T cells alone. Data are
representative of one out three experiments.
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